INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation. By leveraging the natural conditions of the patient’s body, the INVOcell system aims to reduce the complexity, equipment requirements and cost associated with standard IVF lab procedures. INVO Fertility also provides complementary consumables and training programs to support fertility specialists in adopting its technology.

Originating in the early 2010s, INVO Fertility evolved from pioneering in-vivo fertilization research. The company secured U.S. Food and Drug Administration clearance for the INVOcell device in May 2015, marking a significant milestone that enabled commercial distribution. Since then, it has continued to expand its product portfolio and clinical support services to address the needs of fertility clinics and patients worldwide.

INVO Fertility markets and distributes its solutions across the United States and through a network of international partners in regions including Latin America, Europe, Asia-Pacific and the Middle East. The company collaborates with reproductive health professionals to provide hands-on training, technical assistance and ongoing clinical support, aiming to broaden access to cost-effective fertility treatment options globally.

Key Stats

• Today's Range: $1.50 to $1.57
• 50-Day Range: $1.30 to $2.28
• 52-Week Range: $1.27 to $183.60
• Volume: 32,307 shs
• Average Volume: 792,956 shs
• Market Capitalization: $2.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.00
• Consensus Rating: Moderate Buy

INVO Fertility Stock Analysis - MarketRank™

INVO Fertility scored higher than 52% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

INVO Fertility has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

INVO Fertility has a consensus price target of $20.00, representing about 1,233.3% upside from its current price of $1.50.

Amount of Analyst Coverage

INVO Fertility has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of INVO Fertility is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of INVO Fertility is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

INVO Fertility has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.20% of the float of INVO Fertility has been sold short.

Short Interest Ratio / Days to Cover

INVO Fertility has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in INVO Fertility has recently decreased by 25.09%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

INVO Fertility does not currently pay a dividend.

Dividend Growth

INVO Fertility does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, INVO Fertility insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.72% of the stock of INVO Fertility is held by insiders.

Percentage Held by Institutions

12.02% of the stock of INVO Fertility is held by institutions.

Company Calendar

• Last Earnings: 6/02/2026
• Today: 6/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IVF
• Previous Symbol: NASDAQ:INVO
• CIK: 1417926
• Web: www.invobioscience.com
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 10
• Year Founded: 2009

Price Target and Rating

• Average Price Target for INVO Fertility: $20.00
• High Price Target: $20.00
• Low Price Target: $20.00
• Potential Upside/Downside: +1,233.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3,151.46)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.13 million
• Net Margins: -367.34%
• Pretax Margin: -80.19%
• Return on Equity: N/A
• Return on Assets: -23.68%

Debt

• Debt-to-Equity Ratio: 0.15
• Current Ratio: 0.27
• Quick Ratio: 0.25

Sales & Book Value

• Annual Sales: $6.84 million
• Price / Sales: 0.39
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.46 per share
• Price / Book: 0.43

Miscellaneous

• Outstanding Shares: 1,790,000
• Free Float: 1,773,000
• Market Cap: $2.69 million
• Optionable: No Data
• Beta: 2.33